Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

被引:530
作者
Correll, Christoph U. [1 ,2 ,3 ]
Schooler, Nina R. [4 ]
机构
[1] Zucker Hillside Hosp, Div Psychiat Res, Northwell Hlth, Glen Oaks, NY 11004 USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Psychiat & Mol Med, New York, NY USA
[3] Charite, Dept Child & Adolescent Psychiat, Berlin, Germany
[4] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
关键词
schizophrenia; negative symptoms; prevalence; clinical presentation; diagnosis; treatment; DOPAMINE D-3 RECEPTOR; COGNITIVE-BEHAVIORAL THERAPY; ANTIPSYCHOTIC-LIKE ACTIVITY; PHARMACOLOGICAL-TREATMENT; DOUBLE-BLIND; D3; RECEPTOR; HIGH-RISK; EFFICACY; METAANALYSIS; ANTAGONISM;
D O I
10.2147/NDT.S225643
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Schizophrenia is frequently a chronic and disabling disorder, characterized by heterogeneous positive and negative symptom constellations. The objective of this review was to provide information that may be useful for clinicians treating patients with negative symptoms of schizophrenia. Negative symptoms are a core component of schizophrenia that account for a large part of the long-term disability and poor functional outcomes in patients with the disorder. The term negative symptoms describes a lessening or absence of normal behaviors and functions related to motivation and interest, or verbal/emotional expression. The negative symptom domain consists of five key constructs: blunted affect, alogia (reduction in quantity of words spoken), avolition (reduced goal-directed activity due to decreased motivation), asociality, and anhedonia (reduced experience of pleasure). Negative symptoms are common in schizophrenia; up to 60% of patients may have prominent clinically relevant negative symptoms that require treatment. Negative symptoms can occur at any point in the course of illness, although they are reported as the most common first symptom of schizophrenia. Negative symptoms can be primary symptoms, which are intrinsic to the underlying pathophysiology of schizophrenia, or secondary symptoms that are related to psychiatric or medical comorbidities, adverse effects of treatment, or environmental factors. While secondary negative symptoms can improve as a consequence of treatment to improve symptoms in other domains (ie, positive symptoms, depressive symptoms or extrapyramidal symptoms), primary negative symptoms generally do not respond well to currently available antipsychotic treatment with dopamine D-2 antagonists or partial D-2 agonists. Since some patients may lack insight about the presence of negative symptoms, these are generally not the reason that patients seek clinical care, and clinicians should be especially vigilant for their presence. Negative symptoms clearly constitute an unmet medical need in schizophrenia, and new and effective treatments are urgently needed.
引用
收藏
页码:519 / 534
页数:16
相关论文
共 103 条
[1]   Do we still believe in the dopamine hypothesis? New data bring new evidence [J].
Abi-Dargham, A .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 :S1-S5
[2]   Treatment of negative symptoms: Where do we stand, and where do we go? [J].
Aleman, Andre ;
Lincoln, Tania M. ;
Bruggeman, Richard ;
Melle, Ingrid ;
Arends, Johan ;
Arango, Celso ;
Knegtering, Henderikus .
SCHIZOPHRENIA RESEARCH, 2017, 186 :55-62
[3]  
Alphs Larry, 2010, Psychiatry (Edgmont), V7, P26
[4]   The epidemiology of onset and course of schizophrenia [J].
an der Heiden, W ;
Häfner, H .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2000, 250 (06) :292-303
[5]   Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia [J].
an der Heiden, Wolfram ;
Leber, Anne ;
Haefner, Heinz .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (05) :387-396
[6]  
ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49
[7]  
[Anonymous], 2013, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425596.744053
[8]   Pharmacological approaches to treating negative symptoms: A review of clinical trials [J].
Arango, Celso ;
Garibaldi, George ;
Marder, Stephen R. .
SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) :346-352
[9]   Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10 year follow-up study in the OPUS cohort [J].
Austin, Stephen F. ;
Mors, Ole ;
Budtz-Jorgensen, Esben ;
Secher, Rikke Gry ;
Hjorthoj, Carsten R. ;
Bertelsen, Mette ;
Jeppesen, Pia ;
Petersen, Lone ;
Thorup, Anne ;
Nordentoft, Merete .
SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) :84-91
[10]   VALIDATION OF THE 16-ITEM NEGATIVE SYMPTOM ASSESSMENT [J].
AXELROD, BN ;
GOLDMAN, RS ;
ALPHS, LD .
JOURNAL OF PSYCHIATRIC RESEARCH, 1993, 27 (03) :253-258